Stock listing
NASDAQ:FEED ENvue Medical, Inc. Stock
Home listing (NASDAQ) of ENvue Medical, Inc.
Follow ENvue Medical, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:FEED
$0.223 USD -0.033 (-12.7%)
Close on Nov 20, 2026
- Day range
- $0.215 – $0.230 USDNov 20, 2026
- Volume
- 128 sharesNov 20, 2026
- Market cap
- —Left out: price × shares is far from the company's reported size
- 52-week range
- $0.121 – $73.080 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $77,503 USDMedian day 7,300 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:FEED · Home | $0.223 USD | -0.033 (-12.7%) | 128 | $0.230 | $0.230 | $0.215 | $0.255 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:FEED · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.223 | -0.033 | -12.7% | $0.230 | $0.230 | $0.215 | 128 | |
| $0.255 | 0.000 | 0.0% | $0.255 | $0.255 | $0.255 | 1 | |
| $0.255 | +0.005 | +2.0% | $0.255 | $0.255 | $0.255 | 100 | |
| $0.250 | +0.008 | +3.2% | $0.250 | $0.250 | $0.250 | 100 | |
| $0.242 | -0.018 | -6.8% | $0.390 | $0.390 | $0.242 | 102 | |
| $0.260 | -0.003 | -1.1% | $0.263 | $0.400 | $0.195 | 103,255 | |
| $0.263 | -0.017 | -6.1% | $0.398 | $0.398 | $0.263 | 14,699 | |
| $0.280 | -0.025 | -8.3% | $0.300 | $0.300 | $0.212 | 13,745 | |
| $0.305 | -0.037 | -10.8% | $0.260 | $0.400 | $0.260 | 4,165 | |
| $0.342 | +0.082 | +31.5% | $0.342 | $0.342 | $0.342 | 400 | |
| $0.260 | 0.000 | 0.0% | $0.260 | $0.260 | $0.260 | 700 | |
| $0.260 | -0.090 | -25.7% | $0.203 | $0.399 | $0.203 | 6,800 | |
| $0.350 | +0.100 | +40.0% | $0.203 | $0.350 | $0.203 | 1,000 | |
| $0.250 | +0.028 | +12.6% | $0.232 | $0.300 | $0.203 | 48,700 | |
| $0.222 | +0.002 | +0.9% | $0.222 | $0.222 | $0.222 | 800 | |
| $0.220 | -0.030 | -12.0% | $0.232 | $0.262 | $0.220 | 7,400 | |
| $0.250 | 0.000 | 0.0% | $0.250 | $0.400 | $0.250 | 13,800 | |
| $0.250 | 0.000 | 0.0% | $0.220 | $0.250 | $0.220 | 700 | |
| $0.250 | +0.068 | +37.4% | $0.182 | $0.480 | $0.121 | 34,600 | |
| $0.182 | -0.185 | -50.4% | $0.360 | $0.360 | $0.162 | 99,681 | |
| $0.367 | +0.015 | +4.3% | $0.282 | $0.370 | $0.282 | 1,200 | |
| $0.352 | -0.148 | -29.6% | $0.300 | $0.370 | $0.300 | 4,800 | |
| $0.500 | 0.000 | 0.0% | $0.510 | $0.510 | $0.500 | 5,100 | |
| $0.500 | +0.129 | +34.8% | $0.540 | $0.540 | $0.385 | 4,100 | |
| $0.371 | -0.119 | -24.3% | $0.400 | $0.580 | $0.371 | 2,800 | |
| $0.490 | -0.020 | -3.9% | $0.352 | $0.525 | $0.352 | 3,200 | |
| $0.510 | -0.040 | -7.3% | $0.500 | $0.550 | $0.350 | 21,000 | |
| $0.550 | +0.199 | +56.7% | $0.360 | $0.550 | $0.303 | 3,500 | |
| $0.351 | +0.001 | +0.3% | $0.350 | $0.525 | $0.255 | 50,800 | |
| $0.350 | -0.050 | -12.5% | $0.400 | $0.400 | $0.322 | 4,000 | |
| $0.400 | -0.030 | -7.0% | $0.270 | $0.600 | $0.270 | 21,000 | |
| $0.430 | +0.030 | +7.5% | $0.300 | $0.430 | $0.260 | 13,796 | |
| $0.400 | +0.160 | +66.7% | $0.250 | $0.400 | $0.250 | 9,900 | |
| $0.240 | -0.200 | -45.5% | $0.200 | $0.240 | $0.200 | 3,900 | |
| $0.440 | -0.010 | -2.2% | $0.450 | $0.450 | $0.230 | 5,300 | |
| $0.450 | +0.143 | +46.6% | $0.280 | $0.450 | $0.280 | 4,100 | |
| $0.307 | -0.068 | -18.1% | $0.362 | $0.400 | $0.267 | 4,800 | |
| $0.375 | -0.057 | -13.2% | $0.431 | $0.550 | $0.298 | 7,300 | |
| $0.432 | +0.027 | +6.7% | $0.410 | $0.550 | $0.382 | 11,700 | |
| $0.405 | -0.085 | -17.3% | $0.649 | $0.649 | $0.405 | 10,600 | |
| $0.490 | -0.110 | -18.3% | $0.500 | $0.630 | $0.400 | 10,700 | |
| $0.600 | +0.050 | +9.1% | $0.550 | $0.600 | $0.550 | 23,000 | |
| $0.550 | -0.115 | -17.3% | $0.640 | $0.680 | $0.365 | 32,400 | |
| $0.665 | -0.080 | -10.7% | $0.660 | $0.789 | $0.660 | 14,000 | |
| $0.745 | +0.085 | +12.9% | $0.660 | $0.790 | $0.660 | 18,300 | |
| $0.660 | -0.140 | -17.5% | $0.770 | $0.794 | $0.650 | 36,201 | |
| $0.800 | -0.230 | -22.3% | $0.850 | $0.990 | $0.660 | 125,183 | |
| $1.030 | -2.320 | -69.3% | $3.340 | $3.420 | $0.840 | 1,222,300 | |
| $3.350 | -0.230 | -6.4% | $3.600 | $3.600 | $3.330 | 21,900 | |
| $3.580 | +0.010 | +0.3% | $3.630 | $3.680 | $3.540 | 11,014 | |
| $3.570 | -0.070 | -1.9% | $3.590 | $3.863 | $3.500 | 108,449 | |
| $3.640 | -0.640 | -15.0% | $4.100 | $4.100 | $3.600 | 148,700 | |
| $4.280 | +0.250 | +6.2% | $4.040 | $4.620 | $3.900 | 357,600 | |
| $4.030 | +0.200 | +5.2% | $4.000 | $4.100 | $3.900 | 32,400 | |
| $3.830 | -0.280 | -6.8% | $4.160 | $4.180 | $3.770 | 25,300 | |
| $4.110 | -0.200 | -4.6% | $4.260 | $4.270 | $4.049 | 26,600 | |
| $4.310 | +0.110 | +2.6% | $4.420 | $4.420 | $3.870 | 111,300 | |
| $4.200 | +0.060 | +1.4% | $4.200 | $4.608 | $4.092 | 2,764 | |
| $4.140 | -0.276 | -6.3% | $4.008 | $4.200 | $3.936 | 3,231 | |
| $4.416 | -0.120 | -2.6% | $4.668 | $4.764 | $4.416 | 601 | |
| $4.536 | -0.084 | -1.8% | $4.644 | $4.920 | $4.536 | 615 | |
| $4.620 | -0.120 | -2.5% | $4.560 | $4.920 | $4.560 | 502 | |
| $4.740 | +0.048 | +1.0% | $4.680 | $4.872 | $4.476 | 1,290 | |
| $4.692 | -0.132 | -2.7% | $4.848 | $4.980 | $4.692 | 340 | |
| $4.824 | -0.264 | -5.2% | $4.920 | $5.160 | $4.584 | 1,088 |
Splits
4 splits since 2023 · NASDAQ:FEED · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-12 | Consolidation | |
| 1-for-10 | Consolidation | |
| 1-for-11 | Consolidation | |
| 1-for-20 | Consolidation |
- Ticker
- NASDAQ:FEED
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 15, 2026
ENvue Medical Provides Nasdaq Listing Update
Latest news
ENvue Medical Provides Nasdaq Listing Update
Sep 15, 2026
Closed $1.03 (-69.3%) on Sep 15, 2026
ENvue Medical Resumes U.S. Commercial Shipments of NanoVibronix PainShield® and Begins Fulfilling Open Distributor Orders
Sep 9, 2026
Closed $3.64 (-15.0%) on Sep 9, 2026
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange
Sep 2, 2026
Closed $4.11 (-4.6%) on Sep 2, 2026
ENvue Medical, Inc. Announces 1-for-12 Reverse Stock Split
Aug 28, 2026
Closed $4.14 (-6.3%) on Aug 28, 2026
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
Aug 18, 2026
Closed $5.16 (-7.3%) on Aug 18, 2026
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
Aug 12, 2026
Closed $4.90 (+2.5%) on Aug 12, 2026
ENvue Medical Deploys Additional Navigation Platform with Existing Customer, A Leading North Texas Medical Center
Jul 23, 2026
Closed $4.61 (+3.2%) on Jul 23, 2026
ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform
Jul 15, 2026
Closed $5.10 (-8.2%) on Jul 15, 2026
ENvue Medical Unveils Its First Robotic-Assisted, Artificial Intelligence, Feeding Tube Automation Tool
Jul 9, 2026
Closed $6.43 (+12.4%) on Jul 9, 2026
ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network
Jun 5, 2026
Closed $10.43 (+2.2%) on Jun 5, 2026
ENvue Medical, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 28 in the last 12 months · 29 in all · newest Sep 15, 2026 · oldest 2025
Where ENvue Medical, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:FEED · Home listing · This page | NASDAQ | United States | USD |
| BOATS:FEED | BOATS | United States | USD |
| gettex:56R1 | gettex | Germany | EUR |
| Frankfurt:56R1 | Frankfurt | Germany | EUR |
| Munich:56R1 | Munich | Germany | EUR |
| Lang & Schwarz:A41DDH | Lang & Schwarz | Germany | EUR |
| LS Exchange:A41DDH | LS Exchange | Germany | EUR |
Valuation
Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- −26.1%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.34
Team and board
Officers
| Officer | Role |
|---|---|
| Doron Besser | Chief Executive Officer and Director |
| Nicole Fernandez-McGovern | CFO |
| Anat Hofshi | VP Clinical Affairs & Product |
| Marc Waldman | VP Commercial |
| Rita Silberberg | Senior VP & Chief Accounting Officer |
| Tom Dold | VP QA/RA |
| Zenya Gorlik | VP R&D |
| Fred Reuning | Chief Marketing Officer |
Board
| Director | Role |
|---|---|
| David Johnson | Chairman of the Board |
| Alison Geiger Burgett | Director |
| Doron Besser | Chief Executive Officer and Director |
| Lior Buchman | Director |
| Zeev Rotstein | Director |
| Zvi Joseph | Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Aug 17, 2026 | −1.6% |
| Q1 2026 | May 29, 2026 | −2.4% |
| Q4 2025 | Feb 25, 2026 | −14.4% |
| Q3 2025 | Nov 14, 2025 | −5.1% |
| Q2 2025 | Aug 19, 2025 | −15.1% |
| Q1 2025 | May 20, 2025 | −9.2% |
| Q4 2024 | Mar 31, 2025 | −19.1% |
| Q3 2024 | Nov 29, 2024 | −3.1% |
| Q2 2024 | Aug 20, 2024 | +3.6% |
| Q1 2024 | May 14, 2024 | −1.1% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Feb 28, 2024 | −2.9% |
| Q3 2023 | Nov 14, 2023 | +16.7% |
| Q2 2023 | Aug 15, 2023 | −17.7% |
| Q1 2023 | May 16, 2023 | −0.6% |
| Q4 2022 | Mar 1, 2023 | −3.3% |
| Q3 2022 | Nov 14, 2022 | −3.2% |
| Q2 2022 | Aug 16, 2022 | −22.1% |
| Q1 2022 | May 17, 2022 | +6.9% |
| Q4 2021 | Mar 2, 2022 | +3.8% |
| Q3 2021 | Nov 16, 2021 | −10.4% |
Financings
| Raise | Date |
|---|---|
| Equity line of credit (ELOC) facility Announced: up to US$50M Use of proceeds: Advance its next-generation technology platform and evaluate selective strategic acquisition and business development opportunities | Aug 12, 2026 |
Open Financings · Read by 6ix AI from the company's releases
IPO
Withdrawn on Feb 9, 2015. Filed with the SEC to go public on Feb 6, 2014, as Nano Vibronix, Inc.
- Units offered
- 1,500,000 units
- Underwriters' option
- Up to 225,000 more units
- Listing
- NVBXU on the Nasdaq Capital Market · Has applied to list
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Nov 12, 2013 |
| Filed publicly | Feb 6, 2014 |
| Amended 11 times | Newest Jul 21, 2014 |
| Filing withdrawn | Feb 9, 2015 |
Filings
| Filing | Filed |
|---|---|
| RW · Request to withdraw a registration | Feb 9, 2015 |
| S-1/A · Registration statement, amended | Jul 21, 2014 |
| S-1/A · Registration statement, amended | Jul 7, 2014 |
| S-1/A · Registration statement, amended | Jul 1, 2014 |
| S-1/A · Registration statement, amended | Jun 23, 2014 |
| 8-A12B · Registration of shares for listing on an exchange | May 13, 2014 |
| S-1/A · Registration statement, amended | May 12, 2014 |
| S-1/A · Registration statement, amended | May 8, 2014 |
| 8-A12B · Registration of shares for listing on an exchange | May 7, 2014 |
| S-1/A · Registration statement, amended | May 7, 2014 |
All 18 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | May 2, 2014 |
| S-1/A · Registration statement, amended | Apr 30, 2014 |
| S-1/A · Registration statement, amended | Mar 25, 2014 |
| S-1/A · Registration statement, amended | Mar 6, 2014 |
| S-1 · Registration statement | Feb 6, 2014 |
| DRS/A · Draft registration statement, amended | Jan 17, 2014 |
| DRS/A · Draft registration statement, amended | Dec 24, 2013 |
| DRS · Draft registration statement | Nov 12, 2013 |
Open IPO · From the cover of the amended prospectus (S-1/A) filed Jul 21, 2014
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.55M | 2.56M | 2.28M | 752.0K | 1.70M | 623.0K | 530.0K | 318.0K | 239.0K | 229.0K |
| Cost of revenue | 2.40M | 1.05M | 746.0K | 585.0K | 925.0K | 409.0K | 249.0K | 158.0K | 88.0K | 88.0K |
| Gross profit | 153.0K | 1.51M | 1.54M | 167.0K | 770.0K | 214.0K | 281.0K | 160.0K | 151.0K | 141.0K |
| Research and development | 1.76M | 909.0K | 185.0K | 283.0K | 293.0K | 171.0K | 514.0K | 614.0K | 693.0K | 584.0K |
| Operating income | -22.9M | -3.58M | -3.44M | -5.01M | -5.68M | -4.72M | -5.15M | -4.30M | -3.09M | -2.32M |
| Depreciation and amortization | 897.0K | 1.00K | 1.00K | 1.00K | 2.00K | 2.00K | 4.00K | 6.00K | 5.00K | 7.00K |
| EBITDA | -22.0M | -3.58M | -3.44M | -5.01M | -5.68M | -4.72M | -5.15M | -4.30M | -3.09M | -2.31M |
| Interest expense | 135.0K | 135.0K | 347.0K | 147.0K | 15.0K | 37.0K | 0 | |||
| Income before tax | -18.5M | -3.69M | -3.68M | -5.41M | -14.3M | -4.31M | -5.81M | -4.28M | -4.93M | -2.71M |
| Income tax | -307.0K | 19.0K | 29.0K | 35.0K | 32.0K | 15.0K | -17.0K | -127.0K | 38.0K | 117.0K |
| Net income | -18.2M | -3.71M | -3.71M | -5.45M | -14.3M | -4.33M | -5.79M | -4.15M | -4.96M | -2.83M |
| Earnings per share, basic | -26.69 | -137.30 | -23.32 | -3.84 | -11.35 | -0.42 | -0.83 | -0.64 | -1.17 | -0.62 |
| Earnings per share, diluted | -26.69 | -137.30 | -23.32 | -3.84 | -0.57 | -0.42 | -0.83 | -0.64 | -1.17 | -0.62 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.22M | 752.0K | 3.28M | 2.71M | 7.74M | 7.14M | 1.34M | 896.0K | 4.36M | 106.0K |
| Receivables | 289.0K | 98.0K | 318.0K | 9.00K | 200.0K | 25.0K | 111.0K | 95.0K | 24.0K | 6.00K |
| Inventory | 2.34M | 2.19M | 2.73M | 2.17M | 175.0K | 145.0K | 121.0K | 144.0K | 76.0K | 67.0K |
| Current assets | 7.27M | 3.33M | 6.49M | 5.61M | 8.34M | 7.97M | 1.84M | 1.23M | 4.52M | 221.0K |
| Property, plant and equipment | 119.0K | 9.00K | 7.00K | 7.00K | 5.00K | 4.00K | 4.00K | 8.00K | 5.00K | 11.0K |
| Goodwill | 29.1M | |||||||||
| Total assets | 41.1M | 3.63M | 6.67M | 5.88M | 8.62M | 8.23M | 2.04M | 1.58M | 4.87M | 494.0K |
| Accounts payable | 719.0K | 47.0K | 138.0K | 66.0K | 87.0K | 144.0K | 129.0K | 193.0K | 168.0K | 82.0K |
| Current liabilities | 6.66M | 2.72M | 2.45M | 2.32M | 1.90M | 2.90M | 409.0K | 640.0K | 797.0K | 565.0K |
| Total liabilities | 7.63M | 3.00M | 2.69M | 2.65M | 2.31M | 5.83M | 688.0K | 1.12M | ||
| Shareholders' equity | 33.5M | 627.0K | 3.99M | 3.23M | 6.31M | 2.39M | 1.35M | 463.0K | 3.63M | -2.50M |
| Shares outstanding | 1.10M | 37.9K | 186.0K | 1.64M | 1.40M | 21.2M | 4.20M | 3.80M | 3.94M | 2.63M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -9.37M | -2.52M | -3.60M | -7.04M | -4.37M | -3.39M | -3.87M | -3.55M | -2.18M | -1.53M |
| Capital spending | -60.0K | -3.00K | -1.00K | -3.00K | -3.00K | -2.00K | -8.00K | -8.00K | ||
| Free cash flow | -9.43M | -2.52M | -3.60M | -7.04M | -4.37M | -3.39M | -3.56M | -1.54M | ||
| Cash from investing | 88.0K | -3.00K | -1.00K | -3.00K | -3.00K | -2.00K | -8.00K | -8.00K | ||
| Cash from financing | 12.8M | 1.00K | 4.22M | 2.09M | 4.58M | 9.52M | 4.32M | 94.0K | 6.44M | 33.0K |
| Change in cash | 3.50M | -2.53M | 570.0K | -5.02M | 204.0K | 6.20M | 442.0K | -3.46M | 4.25M | -1.51M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| NT 10-Q · Late filing notice | Nov 16, 2026 | Explanation request | SEC |
| 8-K · Current report | Oct 14, 2026 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Sep 4, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 31, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 17, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2026 | Explanation request | SEC |
| 8-K · Current report | Aug 14, 2026 | Meeting outcome | SEC |
| 8-K · Current report | Aug 12, 2026 | Material contract | SEC |
| S-3 · Registration statement | Aug 10, 2026 | Offer document | SEC |
| DEF 14A · Proxy statement | Jul 24, 2026 | Meeting notice | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| PRE 14A · Preliminary proxy statement | Jul 14, 2026 | Meeting notice | SEC |
| 8-K · Current report | Jul 14, 2026 | Management or board change | SEC |
| 8-K · Current report | Jul 10, 2026 | Current report | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jun 22, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 22, 2026 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | May 29, 2026 | Other filings | SEC |
| 424B3 · Prospectus | May 28, 2026 | Offer document | SEC |
| CORRESP · Letter to the SEC | May 26, 2026 | Other filings | SEC |
| UPLOAD · Letter from the SEC | May 26, 2026 | Other filings | SEC |
| S-3 · Registration statement | May 18, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | May 18, 2026 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | May 15, 2026 | Explanation request | SEC |
| 144 · Notice of proposed sale | May 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Apr 17, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Apr 17, 2026 | Big-stake notice | SEC |
| 10-K · Annual report | Apr 15, 2026 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 6, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Feb 26, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 11, 2026 | Insider trade | SEC |
| SCHEDULE 13D · Big-stake notice | Feb 11, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 6, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Feb 6, 2026 | Management or board change | SEC |
| 3/A · Initial statement of ownership, amended | Feb 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Feb 4, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 30, 2026 | Material contract | SEC |
| 3 · Initial statement of ownership | Jan 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 30, 2025 | Management or board change | SEC |
| 3 · Initial statement of ownership | Dec 29, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 23, 2025 | Management or board change | SEC |
| EFFECT · Notice that a registration is effective | Dec 19, 2025 | Other filings | SEC |
| 3 · Initial statement of ownership | Dec 18, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 18, 2025 | Insider trade | SEC |
| 424B3 · Prospectus | Dec 18, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 12, 2025 | Current report | SEC |
| S-3/A · Registration statement, amended | Dec 9, 2025 | Offer document | SEC |
| 8-K · Current report | Dec 5, 2025 | Management or board change | SEC |
| 8-K · Current report | Nov 19, 2025 | Current report | SEC |
| 10-Q · Quarterly report | Nov 14, 2025 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Nov 10, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Nov 10, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Oct 30, 2025 | Meeting notice | SEC |
| 8-K · Current report | Oct 30, 2025 | Management or board change | SEC |
| S-3/A · Registration statement, amended | Oct 6, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 17, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Sep 17, 2025 | Offer document | SEC |
| S-3 · Registration statement | Sep 15, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 19, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 14, 2025 | Management or board change | SEC |
| NT 10-Q · Late filing notice | Aug 14, 2025 | Explanation request | SEC |
| 8-K · Current report | Aug 8, 2025 | Current report | SEC |
| 8-K · Current report | Jul 30, 2025 | Management or board change | SEC |
| 8-K · Current report | Jul 22, 2025 | Material contract | SEC |
| 8-K · Current report | Jul 18, 2025 | Meeting outcome | SEC |
| 8-K · Current report | Jul 11, 2025 | Current report | SEC |
| 8-K · Current report | Jul 9, 2025 | Current report | SEC |
| DEFA14A · Additional proxy material | Jun 25, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jun 20, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jun 9, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jun 4, 2025 | Management or board change | SEC |
| 10-Q · Quarterly report | May 20, 2025 | Quarterly report | SEC |
| SCHEDULE 13G · Big-stake notice | May 19, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 16, 2025 | Material contract | SEC |
| 424B4 · Prospectus | May 16, 2025 | Offer document | SEC |
| NT 10-Q · Late filing notice | May 15, 2025 | Explanation request | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | May 15, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 14, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 14, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | May 14, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | May 12, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | Apr 29, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | Apr 22, 2025 | Offer document | SEC |
| 8-K · Current report | Apr 11, 2025 | Material contract | SEC |
| 8-K · Current report | Apr 3, 2025 | Management or board change | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 14, 2025 | Current report | SEC |
| 8-K · Current report | Mar 12, 2025 | Current report | SEC |
| 8-K · Current report | Feb 25, 2025 | Meeting outcome | SEC |
| UPLOAD · Letter from the SEC | Feb 20, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| S-1 · Registration statement | Feb 14, 2025 | Offer document | SEC |
| 8-K · Current report | Feb 14, 2025 | Acquisition or disposal | SEC |
| DEF 14A · Proxy statement | Jan 27, 2025 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jan 16, 2025 | Meeting notice | SEC |
| 8-K · Current report | Jan 7, 2025 | Financing | SEC |
| 8-K · Current report | Jan 6, 2025 | Current report | SEC |
| 4 · Change in ownership | Jan 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Dec 20, 2024 | Management or board change | SEC |
| 8-K · Current report | Dec 19, 2024 | Current report | SEC |
| 8-K · Current report | Dec 11, 2024 | Current report | SEC |
| 8-K · Current report | Nov 22, 2024 | Current report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 14, 2024 | Quarterly report | SEC |
| ARS · Annual report to shareholders | Oct 29, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Oct 29, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 29, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 11, 2024 | Current report | SEC |
| 8-K · Current report | Oct 7, 2024 | Current report | SEC |
| 8-K · Current report | Sep 25, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 16, 2024 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | Apr 26, 2024 | Annual report | SEC |
| 8-K · Current report | Apr 15, 2024 | Current report | SEC |
| 10-K/A · Annual report, amended | Apr 9, 2024 | Annual report | SEC |
| 8-K · Current report | Apr 9, 2024 | Current report | SEC |
| 10-K · Annual report | Apr 8, 2024 | Annual report | SEC |
| NT 10-K · Late filing notice | Apr 1, 2024 | Explanation request | SEC |
| 8-K · Current report | Mar 28, 2024 | Material contract | SEC |
| 4 · Change in ownership | Feb 26, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 26, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 23, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 14, 2024 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Jan 17, 2024 | Meeting notice | SEC |
| 8-K · Current report | Jan 17, 2024 | Current report | SEC |
| 8-K · Current report | Dec 11, 2023 | Current report | SEC |
| 4 · Change in ownership | Dec 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 4, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 4, 2023 | Management or board change | SEC |
| DEFA14A · Additional proxy material | Nov 29, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Nov 29, 2023 | Meeting notice | SEC |
| 8-K · Current report | Nov 28, 2023 | Current report | SEC |
| 8-K · Current report | Nov 21, 2023 | Current report | SEC |
| 8-K · Current report | Nov 14, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2023 | Current report | SEC |
| 8-K · Current report | Sep 27, 2023 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Sep 22, 2023 | Other filings | SEC |
| 424B3 · Prospectus | Sep 21, 2023 | Offer document | SEC |
| RW · Request to withdraw a registration | Sep 21, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 19, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Sep 19, 2023 | Other filings | SEC |
| D | Sep 13, 2023 | Other filings | SEC |
| S-3 · Registration statement | Sep 12, 2023 | Offer document | SEC |
| 8-K · Current report | Sep 6, 2023 | Current report | SEC |
| 8-K · Current report | Sep 1, 2023 | Material contract | SEC |
| 8-K · Current report | Aug 30, 2023 | Current report | SEC |
| 8-K · Current report | Aug 29, 2023 | Current report | SEC |
| 8-K · Current report | Aug 28, 2023 | Current report | SEC |
| 8-K · Current report | Aug 23, 2023 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Aug 14, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| CORRESP · Letter to the SEC | Aug 9, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Aug 9, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Aug 7, 2023 | Offer document | SEC |
| S-3 · Registration statement | Aug 1, 2023 | Offer document | SEC |
| 8-K · Current report | Jul 20, 2023 | Current report | SEC |
| S-1 · Registration statement | Jul 17, 2023 | Offer document | SEC |
| 8-K · Current report | Jun 21, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Jun 14, 2023 | Current report | SEC |
| 8-K · Current report | May 25, 2023 | Current report | SEC |
| DEFA14A · Additional proxy material | May 18, 2023 | Meeting notice | SEC |
| 8-K · Current report | May 18, 2023 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| ARS · Annual report to shareholders | May 1, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | May 1, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | May 1, 2023 | Meeting notice | SEC |
| 8-K · Current report | Apr 19, 2023 | Current report | SEC |
| 10-K · Annual report | Apr 17, 2023 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2023 | Explanation request | SEC |
| 8-K · Current report | Mar 28, 2023 | Current report | SEC |
| 8-K · Current report | Mar 21, 2023 | Current report | SEC |
| 8-K · Current report | Mar 14, 2023 | Current report | SEC |
| 8-K · Current report | Mar 3, 2023 | Current report | SEC |
| 8-K · Current report | Feb 22, 2023 | Current report | SEC |
| 8-K · Current report | Feb 8, 2023 | Current report | SEC |
| 8-K · Current report | Jan 18, 2023 | Current report | SEC |
| 4 · Change in ownership | Jan 5, 2023 | Insider trade | SEC |
| 8-K · Current report | Dec 15, 2022 | Management or board change | SEC |
This page holds 200 of 552 filings. Open Filings
Cap table
Built by 6ix from ENvue Medical, Inc.’s releases · as of Aug 12, 2026
- Common shares
- 923,717
- Fully diluted
- 923,717
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 923,717 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 923,717 |
| Aug 28, 2026 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Nicole Fernandez-McGovern Other companies: MGO Global Inc. (Director · Jan 13, 2023 – Nov 28, 2023 · Past); AgEagle Aerial Systems, Inc. (Chief Financial Officer · Mar 26, 2018 – Sep 30, 2023 · Past) | CFO · Since at least Dec 18, 2025 |
| Alison Geiger Burgett Other companies: AgEagle Aerial Systems, Inc. (Chief Financial Officer · Since at least May 22, 2025) | Director · Since at least Dec 4, 2025 |
| Harold Jacob Other companies: Oramed Pharmaceuticals Inc. (Director · Aug 8, 2012 – Mar 10, 2016 · Past) | Chief Medical Officer, Director · Apr 10, 2015 – Dec 30, 2024 · Past |
| Anat Hofshi | VP Clinical Affairs & Product · Since at least Nov 4, 2026 |
| Brian M Murphy | Chief Executive Officer, Director · Nov 15, 2023 – Dec 30, 2024 · Past |
| Christopher M Fashek | Director · Sep 29, 2020 – Dec 30, 2024 · Past |
| David Johnson | Chairman of the Board · Since at least Dec 15, 2025 |
| Doron Besser | Chief Executive Officer and Director · Since at least Sep 15, 2026 |
| Fred Reuning | Chief Marketing Officer · Since at least Nov 4, 2026 |
| Lior Buchman | Director · Since at least Jul 15, 2026 |
All 19 people
| Person | Seat |
|---|---|
| Marc Waldman | VP Commercial · Since at least Jan 21, 2026 |
| Michael Ferguson | Director · Nov 15, 2023 – Dec 30, 2024 · Past |
| Pellegrino Pionati | Director · Since at least Dec 4, 2025 |
| Rita Silberberg | Senior VP & Chief Accounting Officer · Since at least Nov 4, 2026 |
| Stephen Russell Brown | Chief Financial Officer · Jun 14, 2022 – Dec 30, 2024 · Past |
| Tom Dold | VP QA/RA · Since at least Nov 4, 2026 |
| Zeev Rotstein | Director · Since at least Feb 14, 2025 |
| Zenya Gorlik | VP R&D · Since at least Nov 4, 2026 |
| Zvi Joseph | Director · Since at least Jul 15, 2026 |
Log in to ask 6ix AI your own questions about ENvue Medical, Inc.